At the end of week 1, you meet FDA target
71% of MPC-treated patients who achieved ACR20 responses did so as early as week 1
At week 12 your drug exceeds it and placebo goes nowhere
At week 12, 27% of MPC-treated patients, but no placebo-treated controls, achieved ACR50 or ACR 70 responses
At this LOW dose, 20% of patients show remission
Remission at week 12, as defined by Disease Activity Score (DAS28/CRP) <2.6, was seen in 20% of MPC-treated patients but in no controls.
These are the least responsive group of patients they could find and they got a good result
GLTAH
- Forums
- ASX - By Stock
- MSB
- Ann: MSB Therapy Shows Benefit In First Cohort Of RA Patients
Ann: MSB Therapy Shows Benefit In First Cohort Of RA Patients, page-4
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
92.5¢ |
Change
0.010(1.09%) |
Mkt cap ! $1.056B |
Open | High | Low | Value | Volume |
90.5¢ | 94.0¢ | 89.5¢ | $4.970M | 5.436M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 18877 | 92.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
92.5¢ | 6795 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 0.960 |
1 | 612 | 0.955 |
1 | 105 | 0.940 |
3 | 135977 | 0.935 |
3 | 43808 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.900 | 200 | 1 |
0.920 | 20143 | 2 |
0.935 | 20070 | 2 |
0.940 | 55000 | 2 |
0.950 | 5000 | 1 |
Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |